APA način citiranja (7. izdanje)

Chakravarthy, U., Harding, S., Rogers, C., Downes, S., Lotery, A., Wordsworth, S., & Reeves, B. (2012). Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration.

Čikaški stil citiranja (17. izdanje)

Chakravarthy, U., S. Harding, C. Rogers, S. Downes, A. Lotery, S. Wordsworth, i B. Reeves. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.

MLA način citiranja (9. izdanje)

Chakravarthy, U., et al. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.